Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 1997, Bay City Capital LLC is a life sciences investment firm located in the San Francisco Bay Area. The firm manages five venture capital funds with total capital commitments of $1.3 billion and has invested in over 100 companies globally.
Bay City Capital invests in life sciences companies, including biopharmaceuticals, medical devices, diagnostics, healthcare IT, nutrition, and agribusiness. They participate in funding from seed stage through to public companies, targeting innovation and growth opportunities.
Notable companies in Bay City Capital's portfolio include Nevro (Past IPO), Dermira (Past IPO), and Map Pharmaceuticals (Acquired by Allergan). Other investments include Oculis, Gritstone Oncology, Imara, Kezar Life Sciences, NextCure, and Synchronicity Pharma.
Submit your pitch through their website's contact form.
Bay City Capital invests across multiple stages, including seed, Series A, Series B, Series C, and IPO.
The firm focuses on life sciences, specifically biopharmaceuticals, medical devices, diagnostics, healthcare IT, nutrition, and agribusiness.
Bay City Capital manages a total of $1.3 billion across five venture capital funds.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.